Teva Pharma (TEVA), Active Biotech Initiate ARPEGGIO Trial

November 4, 2014 8:03 AM

Teva Pharma (NYSE: TEVA) and Active Biotech announced the expansion of the laquinimod clinical development program with the initiation of ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found